Population-Based Evidence for the Use of Serum Neurofilaments as Individual Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis.

Simon WitzelAndré HussGabriele NagelAngela RosenbohmDietrich RothenbacherRaphael S PeterHansjörg BäznerAxel BörtleinSilke DempewolfMartin SchabetMartin HechtAndreas KohlerChristian OpherkAndrea NaegeleNorbert SommerAlfred LindnerChristoforos AlexudisFranziska BachhuberSteffen HalbgebauerDavid BrennerWolfgang RufUlrike WeilandBenjamin MayerJoachim SchusterJohannes DorstHayrettin TumaniAlbert C Ludolphnull null

Published in: Annals of neurology (2024)

Population-based assessment enhances the utility of particularly serum NfL as a diagnostic and prognostic biomarker in ALS and improves the translation of findings from controlled cohorts to real-world populations. ANN NEUROL 2024.

Keyphrases